EPS Bio Technology Corp. (TPEX:4183)
14.00
+0.55 (4.09%)
May 8, 2026, 12:59 PM CST
EPS Bio Technology Market Cap
EPS Bio Technology has a market cap or net worth of 333.2 million as of May 8, 2026. Its market cap has decreased by -38.33% in one year.
Market Cap
333.20M
Enterprise Value
374.51M
Revenue
443.44M
Ranking
n/a
PE Ratio
n/a
Stock Price
14.00
Market Cap Chart
Since November 13, 2012, EPS Bio Technology's market cap has decreased from 354.00M to 333.20M, a decrease of -5.88%. That is a compound annual growth rate of -0.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 333.20M | -15.66% |
| Dec 31, 2025 | 395.08M | -28.45% |
| Dec 31, 2024 | 552.16M | -12.29% |
| Dec 29, 2023 | 629.51M | 42.97% |
| Dec 30, 2022 | 440.30M | 0.54% |
| Dec 30, 2021 | 437.92M | -14.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AViTA | 1.16B |
| Wiltrom | 1.07B |
| PlexBio | 1.07B |
| S&S Healthcare Holding | 961.91M |
| Radiant Innovation | 802.38M |
| AmCad BioMed | 747.33M |
| Carilex Medical | 690.34M |
| Health & Life | 509.63M |